Quality-of-life issues in the treatment of testicular cancer

被引:49
作者
Heidenreich, A [1 ]
Hofmann, R [1 ]
机构
[1] Univ Marburg, Dept Urol, D-35033 Marburg, Germany
关键词
germ cell tumor; quality of life; sexuality; fertility; psychological morbidity; long-term survival;
D O I
10.1007/s003450050138
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Quality of life (QOL) issues in testis cancer have recently assumed great importance for both physicians and patients. Since most of the patients are going to be long-term survivors, with modern therapeutic approaches, psychosocial difficulties and sexual life problems may become one of the major long-term complications of testis cancer treatment. QOL studies available demonstrate that approximately 10% of the patients will suffer from enduring long-term psychological problems, namely anxiety, depression, fatigue, and disrupted intimate relationships. Since these problems develop unrelated to the therapeutic approach, one has to develop risk profiles predicting psychological illness, such as with psychological counseling, prior to the initiation of the therapy. Impairment of sexual life and infertility distress represent other long-term sequelae of testis cancer treatment. The highest incidence of sexual dysfunction develops within the first 6 months following therapy, with most patients recovering within the next 3 years, resulting in a 15% rate of long-term sexual dysfunction. This relatively high frequency of sexual problems warrants an adequate counseling before and after therapy. Future perspectives of QOL research in testis cancer has to concentrate on the development of a site- specific questionnaire. Since the different therapeutic strategies in clinical stage 1 testis cancer result in the same high cure rates but may encounter various levels of psychosocial distress, QOL appears to represent the most important endpoint end of different treatment modalities in the clinical setting of different treatment modalities and QOL documentation must be integrated in all clinical study protocolls. QOL studies are important issues in the evaluation of each new future method of treatment modality going to be established for testis cancer.
引用
收藏
页码:230 / 238
页数:9
相关论文
共 44 条
[1]   PRETREATMENT AND POSTTREATMENT SEXUAL LIFE IN TESTICULAR CANCER-PATIENTS - A DESCRIPTIVE INVESTIGATION [J].
AASS, N ;
GRUNFELD, B ;
KAALHUS, O ;
FOSSA, SD .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1113-1117
[2]   Psychosocial aspects in long-term survivors of testicular cancer [J].
Arai, Y ;
Kawakita, M ;
Hida, S ;
Terachi, T ;
Okada, Y ;
Yoshida, O .
JOURNAL OF UROLOGY, 1996, 155 (02) :574-578
[3]   COMPLICATIONS OF PRIMARY RETROPERITONEAL LYMPH-NODE DISSECTION [J].
BANIEL, J ;
FOSTER, RS ;
ROWLAND, RG ;
BIHRLE, R ;
DONOHUE, JP .
JOURNAL OF UROLOGY, 1994, 152 (02) :424-427
[4]   PSYCHOSOCIAL OUTCOMES OF CANCER - A COMPARATIVE-ANALYSIS OF HODGKINS-DISEASE AND TESTICULAR CANCER [J].
BLOOM, JR ;
FOBAIR, P ;
GRITZ, E ;
WELLISCH, D ;
SPIEGEL, D ;
VARGHESE, A ;
HOPPE, R .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :979-988
[5]  
Brunner K, 1991, AKT ONKOL, V63, P54
[6]   Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy [J].
Culine, S ;
Theodore, C ;
TerrierLacombe, MJ ;
Droz, JP .
JOURNAL OF UROLOGY, 1996, 155 (04) :1296-1298
[7]   Primary treatment in stage II non-seminomatous germ cell tumours of the testis: A matter of scalpel or drug infusion? [J].
Culine, S ;
Droz, JP .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) :1641-1644
[8]  
CULLEN MH, 1994, BR J CANC S21, V69, P14
[9]   NERVE-SPARING RETROPERITONEAL LYMPHADENECTOMY WITH PRESERVATION OF EJACULATION [J].
DONOHUE, JP ;
FOSTER, RS ;
ROWLAND, RG ;
BIHRLE, R ;
JONES, J ;
GEIER, G ;
JEWETT, MAS .
JOURNAL OF UROLOGY, 1990, 144 (02) :287-292
[10]   POSTORCHIECTOMY RADIOTHERAPY FOR STAGE-I AND STAGE-II TESTICULAR SEMINOMA [J].
DOSMANN, MA ;
ZAGARS, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (03) :381-390